This live course addresses the diagnosis and treatment of pediatric retinal diseases and the use of gene therapy in hereditary retinal diseases. Case scenarios and surgical examples are provided.
1. To better understand the presence and course of various conditions in the spectrum of pediatric retinal disease including disorder pathophysiology, clinical features, management options, and typical treatment course.
2. To understand the mechanism of action and current status of gene and cell therapies for inherited retinal dystrophies and degenerations and how these therapies are altering the treatment of hereditary retinal diseases, potentially restoring vision or slowing the progression of vision loss.
This live activity is designated for a maximum of 1 CE Credit by COPE (Course Number 70793-PS, Activity 118664).
The Michigan State Medical Society designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Michigan State Medical Society and Foundation for Vision Research. The Michigan State Medical Society is accredited by the ACCME to provide continuing medical education for physicians.